Navigation Links
Helix BioPharma Reports On 2009 Annual General Meeting
Date:12/9/2009

AURORA, Ontario, Dec. 9 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) reports that at its Annual General Meeting held today, shareholders approved all of management's proposals.

Board of Directors

All seven Board members were re-elected as directors, with the Board continuing to be constituted of:


Donald H. Segal, Chairman of the Board and Chief Executive Officer
Kenneth A. Cawkell, Director and Corporate Secretary
John Docherty Director, President and Chief Operating Officer
Thomas Hodgson, Director
Jack Kay, Director
Gordon M. Lickrish, Director
Kazimierz Roszkowski-Sliz, Director

Auditor

KPMG LLP was re-appointed as the Company's auditor.

By-Law No. 1 (2009)

The shareholders approved the repeal of former By-Law No. 1 and the adoption of new By-law No. 1 (2009) of the Company. By-law No. 1 (2009) as approved is being filed on SEDAR at www.sedar.com and on EDGAR at www.sec.gov/edgar.shtml.

Corporate Presentation

The slide show portion of the corporate presentation given at the meeting has been posted on the Company's website at www.helixbiopharma.com.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is listed on the TSX and FSE under the symbol "HBP" and on the OTCQX International Market under the symbol "HXBPF".


For further in
'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
2. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
3. Helix BioPharma Corp. Announces Fiscal 2009 Results
4. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
5. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
6. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
7. Seven New Biopharmaceutical Research Companies Join PhRMAs Mission to Advance Medical Innovation
8. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
9. PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share
10. Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... VEGAS , July 30, 2014  DigiPath, Inc. ... that is expanding into the cannabis testing and education ... in its business and affairs not previously disclosed or, ... the recent unusual market action. "We have ... over the last three trading days," said Steve ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... , , SAN DIEGO , Jan. 15 ... entry of a settlement agreement which will resolve the consolidated securities ... Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay ... the company has agreed to issue to the plaintiffs, class a ...
... , , , , , , ... Jan. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... a,leading fully integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has relocated its headquarters to its new buildings,in ...
Cached Medicine Technology:Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 2Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 3Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit 4China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 2China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 3
(Date:7/30/2014)... According to the market research report ... Technology (ICS, MES, ERP, ITS), Field Devices, Products ... (Process, Discrete) - Global Forecast & Analysis to ... market is expected to reach $6.99 Billion at ... 70 market data Tables and 96 Figures spread ...
(Date:7/30/2014)... 2014 “Today, we have said ¡Basta! ... are being promoted to our children and our families. ... the beverage industry to put the health of people ... Jane L. Delgado, President and CEO of the National ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 “North America ... market data on the North America Contrast Media Injectors ... dollars, and volume (in units) and average price data ...     CT Injectors ,     Interventional Cardiology/Angio Injectors and MRI ... contrast agent) is a substance used to enhance the ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The Dr. ... Spohn Health, recently announced the proposed naming of the ... Dr. Hector P. Garcia Family Health Center. , The ... health care services, including comprehensive chronic disease management programs, ... also be a pioneering medical home model center. , ...
(Date:7/30/2014)... Decene is an alkene with ... ten carbon atoms with one double bond. 1-Decene ... It can be used as a co-monomer in ... epoxides, amines, oxo alcohols, synthetic lubricants, synthetic fatty ... will receive 10% customization on this report. , ...
Breaking Medicine News(10 mins):Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 4Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4
... TXStudents, perceptions of their overall experience on campus may ... research has also found a solid relationship between undergraduates, ... quality of life. Are campus green spaces as important ... new study investigating this question revealed some interesting insights. ...
... rule out men who don,t need treatment , MONDAY, ... the standard prostate cancer test can help improve predictions ... report. , The basic test measures blood levels of ... cells. But the standard PSA test cannot distinguish between ...
... 1st Plumbing ... Austin, Texas. The Easy Water system is a revolutionary alternative to salt-based water softeners. The ... your water, without them resulting in hard water buildup. , ... Austin, Texas -- 1st Plumbing Services has been selected as ...
... observational studies show an increased risk for cancer among ... may be worse than currently known. "As ... to see the current disparity in knowledge and outcomes ... of the Institute for Health Promotion Research at the ...
... lung cancer clinical trial to guide targeted therapies to ... a step toward personalized care and more effective, efficient ... during the American Association for Cancer Research 101st Annual ... M. D. Anderson Cancer Center presented the results of ...
... black children in kindergarten, first grade , MONDAY, April ... urban elementary school children, U.S. researchers report. , They ... 44 schools across the bi-state Kansas City metropolitan area, ... with the fungus ( T. tonsurans ) that causes ...
Cached Medicine News:Health News:Campus green space more important for undergrads 2Health News:New Test May Predict Prostate Cancer's Aggressiveness 2Health News:New Test May Predict Prostate Cancer's Aggressiveness 3Health News:1st Plumbing Services Selected to be Exclusive Dealer in Austin, Texas for Installation of Easy Water No-Salt Water Conditioning System 2Health News:1st Plumbing Services Selected to be Exclusive Dealer in Austin, Texas for Installation of Easy Water No-Salt Water Conditioning System 3Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 2Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 3Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 4Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 5Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 6Health News:Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010 7Health News:BATTLE links potential biomarkers to drugs for lung cancer 2Health News:BATTLE links potential biomarkers to drugs for lung cancer 3Health News:BATTLE links potential biomarkers to drugs for lung cancer 4Health News:Resistant Ringworm Common in Urban Elementary Schools 2
... AFO is designed to treat or help ... immobility such as hip displasia, foot drop, ... A comfortable Kodel lining provides a comfortable ... anti-rotation bar is easily rotated and locked ...
... RCAI provides adjustable static stretch of the ... as diminished foot and ankle range of ... straps attached to the sides of the ... be controlled, as needed, in the desired ...
... Splint is indicated for the treatment of ... economical and easy to apply. The splint ... dorsiflexion, limiting nightly contractures and tightening of ... feature permits flexibility in the treatment of ...
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure....
Medicine Products: